DIAGNOSTIC_TEST · Unmapped registry intervention
MS-MLPA Methylation Analysis
Find medicine records ·
Find other trials using this name
Clinical trial
BRCA1, RASSF1A and PTEN Methylation in Breast Lesions of Uncertain Malignant Potential
NCT07416500
Drugs and interventions used in this trial
1 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
No matching interventions in this trial.
Study at a glance
Registry-backedBRCA1, RASSF1A and PTEN Methylation in Breast Lesions of Uncertain Malignant Potential
Design: INTERVENTIONAL · Status: COMPLETED · Phase: NA
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Interventions
MS-MLPA Methylation AnalysisDIAGNOSTIC_TEST
Sponsors & collaborators
Institute of Oncology Ljubljanalead sponsor
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT07416500 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.